New patent for Hisamitsu drug SECUADO

Copyright © DrugPatentWatch. Originally published at https://www.drugpatentwatch.com/blog/

Annual Drug Patent Expirations for SECUADO
Annual Drug Patent Expirations for SECUADO

Secuado is a drug marketed by Hisamitsu and is included in one NDA. It is available from one supplier. There are five patents protecting this drug.

This drug has thirty-four patent family members in nine countries.

The generic ingredient in SECUADO is asenapine. One supplier is listed for this compound. Additional details are available on the asenapine profile page.

For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com

Make Better Decisions with DrugPatentWatch

» Start Your Free Trial Today «

Copyright © DrugPatentWatch. Originally published at
DrugPatentWatch - Make Better Decisions
Scroll to Top